ClinicalTrials.Veeva

Menu

Long-term Outcome of Newborns With an Isolated Small Cerebellum (PECERI)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Cerebellar Hypoplasia

Treatments

Other: Evaluation of the long term neurodevelopmental outcome

Study type

Observational

Funder types

Other

Identifiers

NCT03572868
69HCL18_0273

Details and patient eligibility

About

The decreased cerebellar biometry during second and third trimester ultrasound examination is the main parameter to diagnoses cerebellar and pontocerebellar hypoplasia. Investigators already described that a transverse cerebellar diameter (TCD) below the 5th centile at second or third trimester scan is related to a high rate of fetal malformations, severe intrauterine restriction in growth, chromosomal anomalies and genetic disorders, therefore when facing a TCD below the 5th centile, patients should be referred for oriented sonogram, fetal MRI (Magnetic resonance imaging) and fetal karyotyping.

However, prenatal counseling in case of an isolated decreased cerebellar biometry remains challenging since there are no data in the literature regarding the neurodevelopmental outcome of these newborns. The aim of this work is to evaluate the neurodevelopmental outcome of newborns with a prenatal isolated decreased cerebellar biometry, in order to improve prenatal counseling.

Enrollment

37 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 2nd or the 3rd trimester ultrasound examination realized at the hospital "Femme Mère Enfant" in Lyon between 2008 and 2015
  • Isolated Transverse cerebellar diameter <5th centile
  • Parents who received the information and did not object to participate to the study

Exclusion criteria

  • Decreased Transverse cerebellar diameter with associated malformations diagnosed during prenatal period
  • Family history of neurodevelopmental delay or cognitive impairment
  • Preterm delivery (< 28 WG)
  • Severe restriction in growth at birth (<3e centile)
  • Neonatal asphyxia (pH blood cord < 7)
  • Apgar score < 7 at 5 min of live with transfer to the neonatal intensive care unit

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems